Matthew K. Szot - 03 Dec 2025 Form 4 Insider Report for INVO Fertility, Inc. (IVF)

Reporting relationship: Director
Issuer ticker: IVF
Reported as of: 03 Dec 2025
Net transaction value: -$6.08
SEC form: 4
Accepted by SEC: 05 Dec 2025, 21:40:32 UTC
Prior SEC filing: 17 Nov 2025
Next SEC filing: 31 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Matthew Szot

Key filing fact

Matthew K. Szot filed Form 4 for INVO Fertility, Inc. (IVF) on 05 Dec 2025.

Key facts

This page summarizes Matthew K. Szot's Form 4 filing for INVO Fertility, Inc. (IVF).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Dec 2025, 21:40.

Change

Previous filing in this sequence was filed on 17 Nov 2025.
Current net transaction value: -$6.08.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001401385 Primary reporting owner

Szot Matthew K

Relationship: Director
Address: C/O INVO FERTILITY, INC., 5582 BROADCAST COURT, SARASOTA
Signature: /s/ Matthew Szot
Signature date: 05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IVF transaction

Common stock

Sale

Transaction value: $6.08
Shares: -4
Change %: -57%
Price: $1.52
Shares after: 3
Date: 03 Dec 2025
Ownership: Direct

IVF transaction

Common stock

Other

Transaction value: $0
Shares: -3
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IVF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,646
Date: 03 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,625
Exercise price: $8.08
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person surrendered the shares of Common Stock to the Issuer without receiving any payment or other value in return.

Footnote F2

As adjusted for a 1 for 8 reverse split that occurred on November 28, 2025.

Footnote F3

The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.